Susceptibility of LDL to Oxidative Stress in Obstructive Sleep Apnea

Sleep

Volumn 21, Issue 3, 1998, Pages 290-296

  Wali, S O ^a   Bahammam, A S ^a   Massaeli, H ^a   Pierce, G N ^a   Iliskovic, N ^a   Singal, P K ^a   Kryger, M H ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b ST BONIFACE GENERAL HOSPITAL   (Canada)

Author keywords

Antioxidants; Cardiovascular disease; Hypoxemia; Lipid peroxidation; Sleep apnea

Indexed keywords

ANTIOXIDANT; COPPER; FREE RADICAL; LOW DENSITY LIPOPROTEIN; REACTIVE OXYGEN METABOLITE;

ADULT; AGED; ANOXIA; ARTICLE; BLOOD; COMPARATIVE STUDY; HUMAN; LIPID PEROXIDATION; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; OXIDATIVE STRESS; PHYSIOLOGY; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; SLEEP APNEA SYNDROME; SLEEP STAGE;

ADULT; AGED; ANOXIA; ANTIOXIDANTS; COPPER; FREE RADICALS; HUMANS; LIPID PEROXIDATION; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OXIDATIVE STRESS; POLYSOMNOGRAPHY; POSITIVE-PRESSURE RESPIRATION; REACTIVE OXYGEN SPECIES; SLEEP APNEA SYNDROMES; SLEEP STAGES;

EID: 0032063922     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Yamashiro Y, Kryger MH. Why should OSA be diagnosed and treated? Clin Pulmonary Medicine. 1994; 1(4):1-10.
2. Millman RP, Redline S, Carlisle CC, Assaf AR, Levinson PD. Daytime hypertension in obstructive sleep apnea. Prevalence and contributing factors. Chest 1991; 99(4): 861-6.
3. deCavanagh EM, Fraga CG, Ferder L, Inserra F. Enalapril and captopril enahnce antioxidant defences in mouse tissues. Am J Physiol 1997; 272: R514-18.
4. Williams AJ, Houston D, Finberg S, Lam DC, Kinney JL, Santiago S. Sleep apnea syndrome and essential hypertension. Am J Cardiol 1985; 55: 1019-22.
5. Fletcher EC, DeBehnke RD, Lovoi MS, Gorin AB. Undiagnosed sleep apnea in patients with essential hypertension. Ann Intern Med 1985; 103: 190-5.
6. Lavie P, Ben-Yosef R, Rubin AE. Prevalence of sleep apnea syndrome among patients with essential hypertension. Am Heart J 1984; 108: 373-6.
7. Kryger M, Roos L, Delaive K, Walld R, Horrocks J. Utilization of health care services in patients with severe obstructive sleep apnea. Sleep 1996; S111-16.
8. Weitzenblum E, Krieger J, Apprill M, Vallee E, Ehrhart M, Ratomaharo J, Osward M, Kurtz D. Daytime pulmonary hypertension in patients with obstructive sleep apnea syndrome. Am Rev Respir Dis 1988; 138: 345-9.
9. Hung J, Whiteford EG, Persons RW, Hillman DR. Association of sleep apnoea with myocardial infarction in men. Lancet 1990; 336: 261-4.
10. Partinen M, Guilleminault C. Daytime sleepiness and vascular morbidity at seven-year follow-up in obstructive sleep apnea patients. Chest 1990; 97: 27-32.
11. Palomaki H. Snoring and the risk of ischemic brain infarction. Stroke 1991; 22: 1021-5.
12. He J, Kryger MH, Zorick FJ, Conway W, Roth T. Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients. Chest 1988; 94: 9-14.
13. Partinen M, Jamieson A, Guilleminault C. Long-term outcome for obstructive sleep apnea syndrome patients. Mortality. Chest 1988; 94: 1200-4.
14. Rossner S, Lagerstrand L, Perrson HE, Sachs C. The sleep apnoea syndrome in obesity: risk of sudden death. J Intern Med. 1991. 230(2): 135-41.
15. Fruebis J, Steinberg D, Dresel HA, Carew TE. A comparison of the antiatherogenic effects of probucol and of a structural analogue of probucol in low density lipoprotein receptor-deficient rabbits. J Clin Invest 1994; 94:392-398.
16. Noguchi N, Gotoh N, Niki E. Dynamics of the oxidation of low density lipoprotein induced by free radicals. Biochim Biophys Acta 1993; 1168:348-357.
17. Sasahara M, Raines EW, Chait A, Carew TE, Steinberg D, Wahl PW, Ross R. Inhibition of hypercholesteremia-induced atherosclerosis in the nonhuman primate by probucol. J Clin Invest. 1994; 94:155-164.
18. Demacker PNM, Hijmans AGM, Kleinveld HA, Stalenhoef AFH. Indications for the presence of circulating peroxidized low density lipoproteins in WHHL rabbits treated with antioxidants. Atherosclerosis 1993;102:69-77.
19. Kleinveld HA, Hak-Lemmers HLM, Stalenhoef AFH, Demacker PNM. Improved measurement of low density lipoprotein susceptibility to copper-induced oxidation: Application of a short procedure for isolating low density lipoprotein. Clin Chem 1992; (38)10:2066-2072,.
20. Liu K, Cuddy TE, Pierce GN. Oxidative status of lipoproteins in coronary disease patients. Am Heart J 1992; 123:285-290.
21. Singal PK, Kirshenbaum LA. A relative deficit in antioxidant reserve may contribute in cardiac failure. Can J Cardiol 1990; 6:47-49.
22. Kaul N, Siveski-Iliskovic N, Hill M, Slezak J, Singal PK. Free radicals and the heart. J Pharmacological and Toxicological Methods. 1993; 30(2): 55-67.
23. Drabkin DL, Austin JH. Spectrophotometric studies. II. Preparation from washed blood cells: nitric oxide hemoglobin and sulfhemoglobin. J Biol Chem 1935; 12:51-65.
24. Paglia DE, Valentine WN. Studies on the qualitative and quantitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967;70:158-169.
25. Clairborne A. Catalase activity. In: Greenwald RA. Handbook of Methods for Oxygen Radical Research. Boca Raton, Florida: CRC Press, 1985: 283-284.
26. Liu K, Pierce GN. The effects of low density lipoprotein on calcium transients in isolated rabbit cardiomyocytes. J Biol Chem 1993; 268: 3767-75.
27. Kutryk MJB, Pierce GN. Effects of low density lipoprotein on calcium movements in cultured vascular smooth muscle cells. Coronary Artery Dis. 1991; 2: 1093-1101.
28. Liu K, Ramjiawan B, Kutryk MJB, Pierce GN. Effects of oxidative modification of cholesterol in isolated low density lipoprotein on cultured smooth muscle cells. Mol Cell Biochem 1991; 108: 49-56.
29. West P, Kryger MH. Continuous monitoring of respiratory variables during sleep by microcomputer. Methods Inf Med 1983; 22:198-203.
30. Rechtschaffen A, Kales A (eds.) A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. Los Angeles: UCLA Brain Information Service/Brain Research Institute, 1968.
31. George CF, Millar TW, Kryger MH. Identification and quantification of apneas by computer based analysis of SaO2. Am Rev Respir Dis 1987; 137:1238-1240.
32. Guilleminault C, Stoohs R, Clerk A, Simmons J, Labanowski M. From obstructive sleep apnea syndrome to upper airway resistance syndrome: consistency of daytime sleepiness. Sleep. 1992 Dec; 15(6 Suppl): S13-6.
33. Kobayashi A, Yamashita T, Kaneko M, Nishiyama T, Hayashi H, Yamazaki N. Effects of verapamil on experimental cardiomyopathy in the Bio 14.6 Syrian hamster. J Am Coll Cardiol 1987;10:1128-1134.
34. Chakravarti RN, Kirshenbaum LA, Singal PK. Atherosclerosis: Its pathophysiology with special reference to lipid peroxidation. J Appl Card 1991;6:91-112.
35. Abdalla DSP, Moriel P. Nitro-tyrosine bound to apolipoproteins as biomarker of peroxynitrate formation in atherosclerosis. Atherosclerosis 1997;134:219 (abstract).
36. Shepard JW Jr. Gas exchange and hemodynamics during sleep. Med Clin North Am 1985; 69: 1243-63.
37. Khalid MA, Ashraf M. Direct detection of endogenous hydroxyl radical production in cultured adult cardiomyocytes during anoxia and reoxygenation: Is the hydroxyl radical really the most damaging radical species? Circ Res 1993;72:725-36.
38. Bolli R. Oxygen derived free radicals and post ischmic myocardial dysfunction ("stunned myocardium"). J Am Coll Cardiol 1988; 12:239-49.
39. Gutteridge JMC, Halliwell B. Reoxygenation injury and antioxidant protection: a tale of two paradoxes. Arch Biochem Biophys 1990; 283:223-226.
40. Hess ML, Manson NH. Molecular Oxygen: Friend and foe. J Mol Cell Cardiol 1984; 16:969-985.
41. Hedner J, Ejnell H, Sellgren J, Hedner T, Wallin G Is high and muscle nerve sympathetic activity in sleep apnea syndrome of pathogenetic importance for the development of hypertension? J Hypertens Suppl (England) 1988; 6(4): S529-31.
42. Singal PK, Kapur N, Dhilon KS, Beamish RE, Dhalla NS. Role of free radicals in catecholamine-induced cardiomyopathy. Can J Physiol Pharmacol 1982;60:1390-1397.
43. Kresiun VI, Rozhkovskii I. V. Disruption of the structural organization of brain mitochondrial membranes during deprivation of the paradoxical sleep phase and correction for it using lithonite. Ukr-BiokhimZh. 1991;May-Jun;63(3):59-65.